<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Dasatinib; Sprycel; Dasatinib" /><meta name="IX" content="Sprycel; Dasatinib" /><meta name="IXM" content="Dasatinib" /><title>DASATINIB: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP5527-dasatinib.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP5527-dasatinib.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP5527-dasatinib.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP5179-malignant-disease-and-immunosuppression.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="PHP5180-cytotoxic-drugs.htm">8.1 Cytotoxic drugs</a> &gt; <a href="PHP5425-other-antineoplastic-drugs.htm">8.1.5 Other antineoplastic drugs</a> &gt; <a href="PHP5514-protein-kinase-inhibitors.htm">Protein kinase inhibitors</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP5514-protein-kinase-inhibitors.htm" title="Previous: Protein kinase inhibitors">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP5528-sprycel.htm#PHP5528-sprycel" title="Next: Sprycel®">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a306020.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dasatinib</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/23086-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Dasatinib</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: D &gt; Interactions of Dasatinib</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="PHP5514-protein-kinase-inhibitors.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Protein kinase inhibitors</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs</p></div></li><li><a href="PHP5528-sprycel.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sprycel®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Protein kinase inhibitors &gt; DASATINIB</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0004s0039.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dasatinib</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; D</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/23086-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dasatinib</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/02829.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dasatinib</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; D &gt; DA</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-D14.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dasatinib</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; D</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E34E3E0R0D383.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Dasatinib</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; D</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>DASATINIB</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int1077-dasatinib.htm">Dasatinib</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">see <a title="target-block: DASATINIB NOTES " href="PHP5514-protein-kinase-inhibitors.htm#PHP5515">notes above </a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="section: Cytotoxic drugs" href="PHP5180-cytotoxic-drugs.htm">section 8.1</a>; susceptibility to QT-interval prolongation (correct hypokalaemia or hypomagnesaemia before starting treatment); risk of cardiac dysfunction (monitor closely); <strong>interactions</strong>: Appendix 1 (dasatinib)</p></div> <div class="cF"><div class="cE"><h3 class="cT">Pulmonary arterial hypertension</h3> <p class="cT">Patients should be evaluated for signs and symptoms of underlying cardiopulmonary disease before starting treatment; echocardiography should be performed at the start of treatment in patients with symptoms of cardiac disease and considered for patients with risk factors for cardiac or pulmonary disease.</p></div><p>Treatment should be interrupted or the dose reduced in patients who develop dyspnoea or fatigue, while they are evaluated for common aetiologies (e.g. pleural effusion, pulmonary oedema, anaemia or lung infiltration); pulmonary arterial hypertension should be considered in the absence of these conditions, and if there is no improvement following dose reduction or interruption.</p><p>If pulmonary arterial hypertension is confirmed, dasatinib should be permanently discontinued</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">manufacturer advises caution in hepatic impairment</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">manufacturer advises avoid unless potential benefit outweighs risk—toxicity in <em>animal</em> studies; effective contraception required during treatment; see also <a title="BNF:target-block: Cytotoxic drugs: Reproductive function" href="PHP5183-side-effects-of-cytotoxic-drugs.htm#PHP5194">Pregnancy and Reproductive Function</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">discontinue breast-feeding</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see <a title="topic: Side-effects of cytotoxic drugs" href="PHP5183-side-effects-of-cytotoxic-drugs.htm">section 8.1</a>; also diarrhoea, anorexia, weight changes, abdominal pain, taste disturbance, constipation, dyspepsia, colitis, gastritis; arrhythmias, congestive heart failure, hypertension, chest pain, flushing, haemorrhage (including gastro-intestinal and CNS haemorrhage), palpitation; dyspnoea, pulmonary hypertension, cough, oedema (more common in patients over 65 years old), pleural effusion; depression, dizziness, headache, insomnia, neuropathy; influenza-like symptoms; musculoskeletal pain; visual disturbances; tinnitus; acne, dry skin, sweating, pruritus, dermatitis, urticaria; <em>less commonly</em> pancreatitis, hepatitis, cholestasis, cholecystitis, oesophagitis, hypotension, transient ischaemic attack, thrombophlebitis, syncope, asthma, seizures, amnesia, tremor, drowsiness, gynaecomastia, irregular menstruation, urinary frequency, proteinuria, hypocalcaemia, rhabdomyolysis, hypersensitivity reactions (including erythema nodosum), photosensitivity, and pigmentation and nail disorders; <em>rarely</em> cor pulmonale; thrombosis and interstitial lung disease also reported</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul> <li><p>Chronic phase chronic myeloid leukaemia, <span class="cP">adult</span> over 18 years 100 mg once daily, increased if necessary to max. 140 mg once daily</p> </li> <li><p>Accelerated and blast phase chronic myeloid leukaemia, acute lymphoblastic leukaemia, <span class="cP">adult</span> over 18 years 140 mg once daily, increased if necessary to max. 180 mg once daily</p> </li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP5528-sprycel.htm#PHP5528-sprycel" title="Sprycel®">Sprycel®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP5514-protein-kinase-inhibitors.htm">Previous: Protein kinase inhibitors</a> | <a class="top" href="PHP5527-dasatinib.htm#">Top</a> | <a accesskey="]" href="PHP5528-sprycel.htm#PHP5528-sprycel" title="Sprycel®">Next: Sprycel®</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>